Medical and Pediatric Oncology · 1997 · 17 citations · 24 references
MedicineGeneticsOncologyCancer GeneticsOncogenesPediatric OncologyCentral Nervous System TumorsMyc Family OncogenesOncogene MutationsPediatric Cancer GeneticsPediatric TumorsTumor Suppressor GenesAmplificationMyc In NeuroblastomaNeuroblastoma BiologyP53 MutationPoint Mutation AnalysisTumor Suppressor P53
The MYCN oncogene is amplified in 20% of childhood neuroblastoma and is associated independently with poor prognosis. Alteration of the p53 tumor supressor gene, in contrast, occurs infrequently in these tumors. In this report, we described a 3-year-old girl with stage IV neuroblastoma. Molecular analysis revealed, both MYCN gene amplification and a point mutation of the p53 tumor supressor gene. To our knowledge, this is the first reported case of neuroblastoma with genetic alterations of both these genes.
24
Principles and Practice of Pediatric Oncology
Annals of Internal Medicine · 1990 · 2K citations
Medicine, Oncology, Pediatrics +12
Conrad T. O. Fong, Nicholas C. Dracopoli, Peter S. White et al. · Proceedings of the National Academy of Sciences · 1989 · 397 citations · Full text